HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Douglas K Price Selected Research

VA 061 (VA061)

12/2008Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.
12/2007Lack of prognostic significance of prostate biopsies in metastatic androgen independent prostate cancer.
8/2007Association of a CYP17 polymorphism with overall survival in Caucasian patients with androgen-independent prostate cancer.
11/2005Polymorphism in the hypoxia-inducible factor 1alpha gene may confer susceptibility to androgen-independent prostate cancer.
12/2004Genotyping and functional analysis of the D104N variant of human endostatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Douglas K Price Research Topics

Disease

64Prostatic Neoplasms (Prostate Cancer)
12/2022 - 01/2002
31Neoplasms (Cancer)
12/2022 - 02/2002
9Neoplasm Metastasis (Metastasis)
01/2018 - 02/2002
6Disease Progression
01/2021 - 03/2006
5Hypoxia (Hypoxemia)
01/2021 - 09/2003
3Osteonecrosis (Kienbock's Disease)
12/2021 - 11/2010
2Neutropenia
03/2018 - 07/2008
2Breast Neoplasms (Breast Cancer)
12/2016 - 08/2006
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
05/2010 - 06/2008
2Carcinogenesis
09/2009 - 05/2008
1Obesity
01/2022
1Osteoporosis
12/2021
1Drug-Related Side Effects and Adverse Reactions
10/2020
1Leukopenia
03/2018
1Cytopenia
03/2018
1Infections
03/2018
1Bacterial Infections (Bacterial Infection)
03/2018
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2013
1Urogenital Neoplasms
03/2013
1Hypocalcemia
01/2012
1Multiple Myeloma
11/2010
1Bisphosphonate-Associated Osteonecrosis of the Jaw
11/2010
1Hypertension (High Blood Pressure)
07/2010
1T-Cell Lymphoma (Lymphoma, T Cell)
02/2009

Drug/Important Bio-Agent (IBA)

21AndrogensIBA
01/2022 - 02/2004
18Androgen Receptors (Androgen Receptor)IBA
01/2021 - 01/2002
9Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2002
9Pharmaceutical PreparationsIBA
12/2021 - 05/2002
9Docetaxel (Taxotere)FDA Link
01/2020 - 08/2006
8Finasteride (Propecia)FDA LinkGeneric
01/2022 - 04/2008
6Proteins (Proteins, Gene)FDA Link
06/2015 - 09/2003
6Thalidomide (Thalomid)FDA Link
07/2008 - 02/2002
5Hormones (Hormone)IBA
01/2022 - 03/2006
5Testosterone (Sustanon)FDA Link
01/2017 - 03/2006
5VA 061 (VA061)IBA
12/2008 - 12/2004
4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
06/2017 - 10/2005
4Prostate-Specific Antigen (Semenogelase)IBA
12/2010 - 09/2002
4DNA (Deoxyribonucleic Acid)IBA
07/2010 - 01/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2009 - 09/2003
3enzalutamideIBA
12/2022 - 06/2015
3EnzymesIBA
12/2022 - 12/2014
3SteroidsIBA
01/2022 - 12/2008
3abirateroneIBA
01/2021 - 12/2014
3Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA
06/2017 - 08/2007
3Dihydrotestosterone (Androstanolone)IBA
06/2015 - 02/2005
3Estrogens (Estrogen)FDA Link
08/2011 - 03/2006
3EndostatinsIBA
12/2004 - 05/2002
2Biological ProductsIBA
01/2022 - 10/2014
2Diphosphonates (Bisphosphonates)IBA
12/2021 - 11/2010
2AnionsIBA
01/2021 - 01/2011
2Peptides (Polypeptides)IBA
01/2021 - 01/2011
2Aromatase (CYP19)IBA
01/2016 - 02/2011
2Transcription Factors (Transcription Factor)IBA
11/2005 - 09/2003
2Angiogenesis InhibitorsIBA
09/2003 - 05/2002
1SolutionsIBA
12/2022
1Serine Proteases (Serine Protease)IBA
12/2022
1Kallikreins (Kallikrein)IBA
12/2022
1Peptide Hydrolases (Proteases)FDA Link
12/2022
1Insulin (Novolin)FDA Link
01/2022
1Insulin-Like PeptidesIBA
01/2022
1gadolinium ethoxybenzyl DTPAFDA Link
11/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1CamptothecinIBA
01/2021
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2021
1Poly Adenosine Diphosphate RiboseIBA
01/2021
1olaparibIBA
01/2021
1IT-101IBA
01/2021
1rucaparibIBA
01/2021
1thiopurine methyltransferase (thiopurine S-methyltransferase)IBA
03/2018
1Azathioprine (Imuran)FDA LinkGeneric
03/2018
1seviteronelIBA
06/2017
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2016
1Tumor Biomarkers (Tumor Markers)IBA
12/2016
1Trastuzumab (Herceptin)FDA Link
12/2016
1Androstenedione (4 Androstene 3,17 dione)IBA
03/2015
1Proto-Oncogene Proteins c-etsIBA
10/2014
1Cell ExtractsIBA
04/2014
1Adrenergic Receptors (Adrenergic Receptor)IBA
11/2013
1Cholinergic ReceptorsIBA
11/2013
1Cholinergic Agents (Cholinergics)IBA
11/2013
1DenosumabFDA Link
01/2012
1EstroneFDA Link
08/2011
1Estradiol (Delestrogen)FDA LinkGeneric
08/2011
1TubulinIBA
02/2011
1Estrogen ReceptorsIBA
02/2011
1Messenger RNA (mRNA)IBA
01/2011
1Cytochrome P-450 CYP2C8IBA
11/2010
1CytochromesIBA
09/2010
1Sorafenib (BAY 43-9006)FDA Link
07/2010
1Bevacizumab (Avastin)FDA Link
07/2010
1Ketoconazole (Nizoral)FDA LinkGeneric
06/2010
1Sarcosine (Methylglycine)IBA
03/2010
1NucleotidesIBA
03/2010
1Small Interfering RNA (siRNA)IBA
10/2009
1romidepsin (FK228)FDA Link
02/2009

Therapy/Procedure

21Therapeutics
12/2022 - 10/2005
17Castration
11/2021 - 06/2010
5Drug Therapy (Chemotherapy)
02/2013 - 03/2006
1Transplantation
03/2018
1Radiotherapy
07/2010